Anti-TFPI2 Antibody

Tissue Factor Pathway Inhibitor 2 (TFPI2) is a Kunitz-type serine protease inhibitor implicated in extracellular matrix remodeling, angiogenesis, and tumor invasion biology. The Antibodies.com Anti-TFPI2 Antibody is a rabbit polyclonal primary antibody raised against human TFPI2 and validated for Western blot and immunohistochemistry workflows. Supplied as 100 µl of a 1 mg/ml stock in PBS with 0.1% sodium azide and 50% glycerol, this unconjugated reagent performs on denaturing gels and fixed tissue sections alike. Researchers investigating cervical, gastric, breast, and colorectal cancer, fibrinolysis, wound healing, and matrix metalloproteinase regulation will find this polyclonal antibody a dependable tool for both routine validation and exploratory experiments. The polyclonal format recognizes multiple epitopes on the TFPI2 target, supporting reproducible detection across diverse sample preparations and lending flexibility to studies of serine protease inhibition, tumor suppressor pathways, and disease-associated changes in TFPI2 expression.